10-Q: Stimcell Energetics Reports Widening Loss, Going Concern Doubt

Stimcell Energetics Inc. reported a significantly increased net loss and a worsening working capital deficit for Q1 2026, raising substantial doubt about its ability to continue as a going concern.

Summary

• Net loss for the three months ended August 31, 2025, increased by 296.9% to $265,602, compared to $66,919 in the prior year.
• Operating expenses surged by 323.2% to $252,354, primarily due to a 747.9% increase in general and administrative expenses and new research and development costs.
• General and administrative expenses rose by $123,033, largely driven by a $114,854 increase in corporate communications fees, totaling $119,224.
• The company incurred $57,309 in research and development costs for the redesign of its eBalance microcurrent device, a project that was previously suspended due to lack of funding.
• Cash balance decreased to $6,437 as of August 31, 2025, from $14,581 at May 31, 2025.
• Working capital deficit worsened by 11.8% to $1,393,949 as of August 31, 2025.
• Accumulated deficit reached $11,127,158.
• The company continues to have no revenue-generating activities.
• Management identified substantial doubt about the company's ability to continue as a going concern.

Sentiment

Score: 2

Explanation: The company faces severe financial distress with a rapidly increasing net loss, worsening working capital deficit, and a critical cash position. The 'going concern' warning and ineffective internal controls highlight significant operational and financial risks. While R&D for a new device is underway, it is capital-intensive and currently unfunded by revenue, relying heavily on related-party debt.

Positives

• Recommenced research and development on the eBalance microcurrent device redesign in partnership with ADM Tronics Unlimited, Inc.
• Secured $100,000 in financing from a related party (Mr. Richard Jeffs) during the quarter, with an additional $50,000 borrowed in September 2025.

Negatives

• Net loss increased significantly by 296.9% to $265,602 for the three months ended August 31, 2025.
• Total operating expenses increased by 323.2% to $252,354.
• General and administrative expenses increased by 747.9%, largely due to corporate communications fees.
• Cash balance declined to $6,437 as of August 31, 2025, indicating a critical liquidity position.
• Working capital deficit worsened to $1,393,949 as of August 31, 2025.
• Accumulated deficit grew to $11,127,158.
• Two related party loans, totaling $60,000, are in default since April 24, 2023.
• Disclosure controls and procedures were deemed ineffective as of August 31, 2025, due to a lack of segregation of duties.
• The company has not achieved profitable operations and has no revenue-generating activities.

Risks

• Going Concern Uncertainty: Substantial doubt exists about the company's ability to continue as a going concern due to an accumulated deficit of $11,127,158, lack of profitable operations, and dependence on external financing.
• Liquidity Risk: The company has a low cash balance of $6,437 and a significant working capital deficit of $1,393,949, indicating insufficient cash flow to meet current obligations.
• Dependence on Related Party Financing: Operations are heavily reliant on loans from directors, officers, and significant shareholders, which may not be sustainable or sufficient.
• Defaulted Loans: Two related party loans, totaling $60,000, are in default, which could strain relationships with key lenders.
• Internal Control Weaknesses: Disclosure controls and procedures were not effective as of August 31, 2025, due to a lack of segregation of duties, posing risks to financial reporting accuracy and compliance.
• Development Stage Company: The company is in an early development stage with no revenue-generating activities, requiring significant capital expenditures for R&D and marketing.
• Project Cost Overruns: The eBalance redesign project has an estimated cost range of $62,500 to $127,000, and actual costs could exceed this.

Future Outlook

Management expects the eBalance microcurrent device redesign project to take approximately 22 to 34 weeks and cost between $62,500 and $127,000. The company plans to support its operations and the redesign project through equity or debt financing, including borrowing from directors and officers, issuing promissory notes, and/or private placement of common stock.

Management Comments

• Management intends to obtain additional funding by borrowing funds from its directors and officers, issuing promissory notes, and/or private placement of common stock.
• The company's vision is to redesign its eBalance to empower individuals to take control of their health from the comfort of home.
• The new version will be smaller and more cost-effective than its predecessors, making microcurrent technology accessible to a broader audience.
• Additionally, it will feature additional diagnostics, including a real-time assessment of cellular energy capacity, treatment tracking, and personalized user profiles.

Industry Context

Stimcell Energetics operates in the biotech and medical device sector, specifically focusing on microcurrent technology for general wellness. The redesign of its eBalance device into a compact, affordable consumer unit for home use aligns with broader industry trends towards personalized health, remote monitoring, and accessible at-home medical solutions, driven by technological advancements and consumer demand for convenience and cost-effectiveness. The partnership with ADM Tronics Unlimited, Inc. suggests a focus on leveraging specialized engineering expertise to compete in this evolving market.

Corporate Governance

Related Party Transactions

• Amounts due to CEO and President: $165,912 (unsecured, due on demand, no interest) as of August 31, 2025.
• Amounts due to CFO: $5,500 (unsecured, due on demand, no interest) as of August 31, 2025.
• Amounts due to an entity controlled by a director: $322,216 (unsecured, due on demand, no interest) as of August 31, 2025.
• Management fees incurred to CEO and President: $22,500 for the three months ended August 31, 2025.
• Consulting fees incurred to CFO: $7,500 for the three months ended August 31, 2025.
• Consulting fees incurred to an entity controlled by a director: $27,330 for the three months ended August 31, 2025.
• Loans from Mr. Richard Jeffs (significant shareholder, father of CEO): $197,394 outstanding (6% and 10% interest, some from credit lines, due on demand) as of August 31, 2025. An additional $50,000 was borrowed in September 2025.
• Loans from Mr. David Jeffs (CEO, director, significant shareholder): $48,837 outstanding (10% interest, unsecured, due on demand) as of August 31, 2025. A $30,000 loan is in default since April 24, 2023.
• Loans from a company of which Mr. David Jeffs is a director: $32,719 outstanding (6% interest, unsecured, due on demand) as of August 31, 2025.
• Loans from Mr. Amir Vahabzadeh (director, significant shareholder): $190,007 outstanding (10% interest, unsecured) as of August 31, 2025. A $30,000 note is in default since April 24, 2023.
• Loans from Mr. Ahdoot (significant shareholder): $74,605 outstanding (10% interest, unsecured, due on demand) as of August 31, 2025.
• Loans from Mrs. Susan Jeffs (mother of CEO): $27,536 outstanding (10% interest, from credit line, due on demand) as of August 31, 2025.
• Advances from an entity controlled by Mr. David Jeffs: $10,915 outstanding (non-interest-bearing, unsecured, due on demand) as of August 31, 2025.

Stakeholder Impact

• Shareholders: Significant dilution risk from potential future equity raises and shares issued for services. Value erosion due to increasing losses and going concern uncertainty.
• Creditors (especially related parties): Increased credit risk due to worsening financial position and defaulted loans. Repayment of debt is uncertain.
• Employees: Potential job insecurity if financial difficulties persist.
• Customers: Future product availability (eBalance device) is dependent on successful R&D and commercialization, which is currently at risk due to funding issues.
• Suppliers: Risk of delayed payments due to liquidity constraints.

Next Steps

• Continue the redesign of the eBalance microcurrent device, expected to take approximately 22 to 34 weeks.
• Seek additional funding through borrowing from directors and officers, issuing promissory notes, and/or private placement of common stock.
• Address the ineffectiveness of disclosure controls and procedures due to lack of segregation of duties.
• Continue issuing shares to Rain Communications Inc. for digital marketing services, with 625,000 shares remaining to be issued.

Key Dates

Recommendation

The company exhibits severe financial distress, marked by a substantial increase in net loss, a rapidly deteriorating working capital deficit, and a critically low cash balance. The explicit 'going concern' warning, coupled with a complete absence of revenue and heavy reliance on related-party debt, signals an unsustainable business model. Furthermore, the disclosure of ineffective internal controls due to a lack of segregation of duties indicates significant governance weaknesses. While R&D for a new device is underway, it is a capital-intensive project with uncertain commercialization prospects, and the company's current financial state makes successful execution highly questionable. The combination of these factors presents an extremely high-risk investment profile with a strong likelihood of further value erosion.

Keywords

Stimcell Energetics, biotech, eBalance, microcurrent device, SEC filing, 10-Q, financial results, net loss, operating expenses, going concern, related party loans, corporate governance, R&D, medical device, wellness products